ChromoGenics AB (publ) is a “Euroclear company” and the shares are electronically registered, the share register is kept by Euroclear Sweden AB, Klarabergsviadukten 63, 111 64 Stockholm.
The company’s shares are listed on Nasdaq First North Growth Market since March 23, 2017.
All shares are of the same class, have equal rights to share the Company’s assets and profits and have one vote each without any special limitations.
Share capital on December 30, 2020 amounted to SEK 3 395 203,8 distributed over 16 976 019 shares with a quota value of SEK 0.20 per share.
ChromoGenics’ shares and warrants are traded on Nasdaq First North Growth Market.